Literature DB >> 28130753

Fluctuation of ROS regulates proliferation and mediates inhibition of migration by reducing the interaction between DLC1 and CAV-1 in breast cancer cells.

Bingwu Yang1, Wenzhen Zhu1, Zhaodi Zheng1, Rongfei Chai1, Shuhua Ji1, Guanghui Ren1, Tingting Liu1, Zhaojun Liu1, Taiyu Song1, Fenglin Li1, Shan Liu1, Guorong Li2.   

Abstract

The aim of our present study was to elucidate the effects of up-regulation and down-regulation of intracellular reactive oxygen species (ROS) level on proliferation, migration, and related molecular mechanism. Breast cancer cells were treated by catalase or H2O2. MTT, colony formation assay, and Hoechst/PI staining were used to evaluate proliferation and apoptosis. The level of intracellular ROS was measured by dichlorodihydrofluorescein diacetate probes. The ability of migration was detected by wound healing. Western blotting and coimmunoprecipitation (co-IP) were used to determine the expression of DLC1 and CAV-1 and their interaction. Our data indicated that up-regulation of intracellular ROS induced by H2O2 significantly inhibited proliferation and induced apoptosis accompanying G1 cell cycle arrest and elevated expression of p53. For cell migration, either up-regulation or down-regulation of ROS induced migration inhibition with reduction of interaction between DLC1 and CAV-1. Our results suggested that up-regulation of intracellular ROS inhibited proliferation by promoting expression of p53 and induced G1 cycle arrest and apoptosis. Fluctuation of ROS inhibited migration through reducing the interaction between DLC1 and CAV-1.

Entities:  

Keywords:  CAV-1; DLC1; Migration; Proliferation; ROS

Mesh:

Substances:

Year:  2017        PMID: 28130753     DOI: 10.1007/s11626-016-0123-0

Source DB:  PubMed          Journal:  In Vitro Cell Dev Biol Anim        ISSN: 1071-2690            Impact factor:   2.416


  36 in total

Review 1.  Matrix metalloproteinases: a tail of a frog that became a prince.

Authors:  Constance E Brinckerhoff; Lynn M Matrisian
Journal:  Nat Rev Mol Cell Biol       Date:  2002-03       Impact factor: 94.444

2.  Tensin1 positively regulates RhoA activity through its interaction with DLC1.

Authors:  Yi-Ping Shih; Peng Sun; Aifeng Wang; Su Hao Lo
Journal:  Biochim Biophys Acta       Date:  2015-09-28

3.  Loss of stromal caveolin-1 expression in colorectal cancer predicts poor survival.

Authors:  Zhi Zhao; Fang-Hai Han; Shi-Bin Yang; Li-Xin Hua; Jian-Hai Wu; Wen-Hua Zhan
Journal:  World J Gastroenterol       Date:  2015-01-28       Impact factor: 5.742

4.  Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma.

Authors:  Fiorella Faggi; Nicola Chiarelli; Marina Colombi; Stefania Mitola; Roberto Ronca; Luca Madaro; Marina Bouche; Pietro L Poliani; Marika Vezzoli; Francesca Longhena; Eugenio Monti; Barbara Salani; Davide Maggi; Charles Keller; Alessandro Fanzani
Journal:  Lab Invest       Date:  2015-03-30       Impact factor: 5.662

5.  Apoptosis or senescence-like growth arrest: influence of cell-cycle position, p53, p21 and bax in H2O2 response of normal human fibroblasts.

Authors:  Q M Chen; J Liu; J B Merrett
Journal:  Biochem J       Date:  2000-04-15       Impact factor: 3.857

Review 6.  The broad spectrum of responses to oxidants in proliferating cells: a new paradigm for oxidative stress.

Authors:  K J Davies
Journal:  IUBMB Life       Date:  1999-07       Impact factor: 3.885

7.  Reactive oxygen species-induced DNA damage and its modification: a chemical investigation.

Authors:  T W Yu; D Anderson
Journal:  Mutat Res       Date:  1997-10-06       Impact factor: 2.433

8.  Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.

Authors:  Xiaoli Du; Xiaolan Qian; Alex Papageorge; Aaron J Schetter; William C Vass; Xi Liu; Richard Braverman; Ana I Robles; Douglas R Lowy
Journal:  Cancer Res       Date:  2012-06-12       Impact factor: 12.701

9.  Antiproliferative activity of rosamultic acid is associated with induction of apoptosis, cell cycle arrest, inhibition of cell migration and caspase activation in human gastric cancer (SGC-7901) cells.

Authors:  Cheng-Guang Sui; Fan-Dong Meng; Yan Li; You-Hong Jiang
Journal:  Phytomedicine       Date:  2015-06-07       Impact factor: 5.340

10.  Deferoxamine promotes MDA-MB-231 cell migration and invasion through increased ROS-dependent HIF-1α accumulation.

Authors:  Yiping Liu; Yongfeng Cui; Miao Shi; Qiang Zhang; Qiang Wang; Xiaodong Chen
Journal:  Cell Physiol Biochem       Date:  2014-04-04
View more
  3 in total

1.  Sequencing Analysis at 8p23 Identifies Multiple Rare Variants in DLC1 Associated with Sleep-Related Oxyhemoglobin Saturation Level.

Authors:  Jingjing Liang; Brian E Cade; Karen Y He; Heming Wang; Jiwon Lee; Tamar Sofer; Stephanie Williams; Ruitong Li; Han Chen; Daniel J Gottlieb; Daniel S Evans; Xiuqing Guo; Sina A Gharib; Lauren Hale; David R Hillman; Pamela L Lutsey; Sutapa Mukherjee; Heather M Ochs-Balcom; Lyle J Palmer; Jessica Rhodes; Shaun Purcell; Sanjay R Patel; Richa Saxena; Katie L Stone; Weihong Tang; Gregory J Tranah; Eric Boerwinkle; Xihong Lin; Yongmei Liu; Bruce M Psaty; Ramachandran S Vasan; Michael H Cho; Ani Manichaikul; Edwin K Silverman; R Graham Barr; Stephen S Rich; Jerome I Rotter; James G Wilson; Susan Redline; Xiaofeng Zhu
Journal:  Am J Hum Genet       Date:  2019-10-24       Impact factor: 11.025

2.  Florfenicol-induced Mitochondrial Dysfunction Suppresses Cell Proliferation and Autophagy in Fibroblasts.

Authors:  Dongfang Hu; Shengliang Cao; Guihua Zhang; Yihong Xiao; Sidang Liu; Yingli Shang
Journal:  Sci Rep       Date:  2017-10-19       Impact factor: 4.379

3.  N-(2'-Hydroxyphenyl)-2-propylpentanamide (OH-VPA), a histone deacetylase inhibitor, induces the release of nuclear HMGB1 and modifies ROS levels in HeLa cells.

Authors:  Arturo Contis-Montes de Oca; Estefanía Rodarte-Valle; Martha Cecilia Rosales-Hernández; Edgar Abarca-Rojano; Saúl Rojas-Hernández; Manuel Jonathan Fragoso-Vázquez; Jessica Elena Mendieta-Wejebe; Ana María Correa-Basurto; Ismael Vázquez-Moctezuma; José Correa-Basurto
Journal:  Oncotarget       Date:  2018-09-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.